Mintz has been recognized as one of the most active and high-performing law firms in biotech in the Patexia 2024 Patent Prosecution Intelligence Report. The report provides a comprehensive overview of the best performing and most active attorneys, law firms, and companies for patent prosecution based on their activity and performance before the USPTO.

Patexia’s Patent Prosecution report covers the period between January 1, 2019, and December 31, 2023, encompassing a total of 1,882,495 patents issued and 1,990,642 applications published by the USPTO. The ranking relies on five high-level factors to measure the overall performance of stakeholders: activity, success, quality, efficiency, and cost. 

The annual report listed Mintz as the 10th Most Active Law Firm in Biotech, 57th Best Performing Law Firm in Biotech, and 48th Most Active Law Firm Overall.

Patexia employs Technology Centers to categorize patents across different domains. The biotech domain includes patents that involve advancements in new drug development, pharmaceutical, and other related life science fields. 

Mintz’s Intellectual Property practice boasts an accomplished team of patent prosecutors and litigators with deep technical backgrounds, making Mintz the ideal counsel to handle post-grant proceedings. Learn more about Mintz’s IP practice here.

Founded in 2010, Patexia Inc. is an intellectual property community and information service. The award methodology includes interviews as an indicator of attorney activity and patent statistics to help determine the rankings.